INS and diabetes mellitus: Continuous exogenous insulin therapy stands as the prevailing treatment modality for individuals afflicted with T1DM, but exogenous insulin does not mimic normal endogenous insulin secretion in the body and may not even control the development of diabetes and its consequences [10, 11].